Companies › ASBP

Aspire Biopharma Holdings Inc (ASBP)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001847345 · EDGAR filings · Updated 2026-07-20

Aspire Biopharma Holdings Inc (ASBP) has reported institutional ownership of 133.1%, with 13 institutional managers holding positions valued at $363.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-20 — Current report (8-K) filed
• 2026-07-02 — SCHEDULE 13G filed
• 2026-06-22 — Current report (8-K) filed
• 2026-06-12 — Current report (8-K) filed
• 2026-06-12 — Current report (8-K) filed
• 2026-05-15 — Quarterly report (10-Q) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Aspire Biopharma Holdings Inc has 13 institutional holders and institutional ownership of 133.1%.

Insider activity

Insiders reported 4 transactions (4 buys, 0 sells) across 1 reporting insiders, with a net reported value of $15.6K.

Data flags from SEC filings

Related companies

NEXALIN TECHNOLOGY INC (NXL) · MUSTANG BIO INC (MBIO) · ACLARION INC (ACON) · ALAUNOS THERAPEUTICS INC (TCRT) · CNS PHARMACEUTICALS INC (CNSP) · MOLECULIN BIOTECH INC (MBRX)